FAKTOR OPTIONSSCHEIN - SMITH & NEPHEW | Real-time BOERSE MUENCHEN 17:25:42 06/06/2024 BST | ||
| 0.393 EUR | -14.94% |
|
| Current month | -50.32% | ||
| 1 month | -51.88% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
| Date | Price | Change |
|---|---|---|
| 06/06/24 | 0.393 | -14.94% |
| 05/06/24 | 0.462 | -46.90% |
| 04/06/24 | 0.87 | -13.86% |
| 03/06/24 | 1.01 | +8.60% |
| 31/05/24 | 0.93 | 0.00% |
Real-time BOERSE MUENCHEN
Last update June 06, 2024 at 05:25 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Goldman Sachs |
| WKN | GG0NPN |
| ISIN | DE000GG0NPN9 |
| Date issued | 05/12/2023 |
| Strike | 1,097 p |
| Maturity | Unlimited |
| Parity | 1.97 : 1 |
| Emission price | 13.53 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.22 € |
|---|---|
| Lowest since issue | 0.366 € |
| Spread | 0.03 € |
| Spread % | 7.32% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13.13
USD
Average target price
16.45
USD
Spread / Average Target
+25.35%
- Stock Market
- Certificates
- Certificat
